mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.7 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |